SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Sean McCarthy will join a roundtable discussion of "How to Transform your Technology into a Sustainable Marketable Product" at the San Jose BioCenter.
News | 03. 22. 2007
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.